News

On April 17, 2018 the Superior Court of Justice had the opportunity to analyze the first Special Appeal addressing the term of … Brazilian Superior Court of Justice decides its first mailbox case

In a decision made available on the 7th of November, Judge of the Supreme Court Luiz Fux dismissed a lawsuit by which … Supreme Court dismisses lawsuit against rule that guarantees a minimum term for patent protection

On August 8 2017 ANVISA officially published the new Rule RDC Nº 168, related to the prior consent of the Agency on patent applications for pharmaceutical products and processes, regulated by Joint Ordinance ANVISA-INPI No. 1, dated April 12, 2017, aiming to a more efficient way to analyze patent applications.

ANVISA has published, on 08/02/2017, in the Federal Register, the the Public Consultation 371/2017 to discuss the extension, from 5 to 10 … Medical Devices – ANVISA´s Public Consultation to extend the registration term

The Ministry of Industry and Commerce (MDIC) and the Brazilian Patent and Trademark Office (INPI) have opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil, aiming to deal in a swift manner with the ever increasing backlog of patent applications awaiting examination, currently exceeding the figure of 230.000.

The Ministry of Industry and Commerce (MDIC) and the Brazilian Patent and Trademark Office (INPI) have opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil, aiming to deal in a swift manner with the ever increasing backlog of patent applications awaiting examination, currently exceeding the figure of 230.000.

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial … São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

ANVISA has informed in its website, on 07/04/2017, the undertake of an operation that determined the shutdown, for at least 30 days, of a manufacturing line of personalized face and skull prostheses.
According to ANVISA, the Senai Joinville (a branch of the National Industrial Apprentice Service) has been manufacturing customized prostheses without authorization of the regulatory agency.

This is the sixth edition of the IAM Patent 1000 – The World's Leading Patent Professionals, a guide that identifies leading firms and patent professionals around the world. Kasznar Leonardos is once again ranked in the gold category of the guide, positioning itself among the market leaders.

With the aim of expanding the office's operations and reinforcing its growth strategy, we announce the arrival of the lawyer Fernanda Magalhães, who will lead an important area for the development of KL: Marketing & Entertainment Law.

Kasznar Leonardos was featured in the ranking Innovation – Technology and Intellectual Property 2017, released by the Leaders League. The firm was classified in 8 categories, having 11 partners mentioned in the publication. 

The guide, which is already in its 7th edition, identifies and highlights, through qualitative research, the firms and leading trademark experts in 72 jurisdictions. 

The office was once again placed in Band 1 , the highest
place in the ranking.

Anderson Ribeiro assumes the Regulatory Law area of the office, focusing on Life Science Team.

It is with joy the we announce, once again, the first placement of Kasznar Leonardos in the ranking of the trademark guide WTR 1000 – 2016.